235 related articles for article (PubMed ID: 15289387)
21. Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Whitlock RP; Sun JC; Fremes SE; Rubens FD; Teoh KH
Chest; 2012 Feb; 141(2 Suppl):e576S-e600S. PubMed ID: 22315272
[TBL] [Abstract][Full Text] [Related]
22. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
[TBL] [Abstract][Full Text] [Related]
23. On-X aortic valve replacement patients treated with low-dose warfarin and low-dose aspirin.
Oo AY; Loubani M; Gerdisch MW; Zacharias J; Tsang GM; Perchinsky MJ; Hagberg RC; Joseph M; Sathyamoorthy M
Eur J Cardiothorac Surg; 2024 May; 65(5):. PubMed ID: 38621698
[TBL] [Abstract][Full Text] [Related]
24. Early Antithrombotic Therapy after Bioprosthetic Aortic Valve Replacement in Elderly Patients: A Single-Center Experience.
Lee SI; Lee KS; Kim JB; Choo SJ; Chung CH; Lee JW; Jung SH
Ann Thorac Cardiovasc Surg; 2017 Jun; 23(3):128-134. PubMed ID: 28367855
[TBL] [Abstract][Full Text] [Related]
25. Anticoagulation or antiplatelet therapy of bioprosthetic heart valves recipients: an unresolved issue.
Colli A; Verhoye JP; Leguerrier A; Gherli T
Eur J Cardiothorac Surg; 2007 Apr; 31(4):573-7. PubMed ID: 17317197
[TBL] [Abstract][Full Text] [Related]
26. Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement.
Christersson C; James SK; Lindhagen L; Ahlsson A; Friberg Ö; Jeppsson A; Ståhle E
Heart; 2020 Jun; 106(11):838-844. PubMed ID: 31757813
[TBL] [Abstract][Full Text] [Related]
27. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial.
Puskas J; Gerdisch M; Nichols D; Quinn R; Anderson C; Rhenman B; Fermin L; McGrath M; Kong B; Hughes C; Sethi G; Wait M; Martin T; Graeve A;
J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1202-1210; discussion 1210-1. PubMed ID: 24512654
[TBL] [Abstract][Full Text] [Related]
28. Antiplatelet therapy in children with left-sided mechanical prostheses.
LeBlanc JG; Sett SS; Vince DJ
Eur J Cardiothorac Surg; 1993; 7(4):211-5. PubMed ID: 8481259
[TBL] [Abstract][Full Text] [Related]
29. Preliminary experience with aspirin for anticoagulation in children with prosthetic cardiac valves.
Weinstein GS; Mavroudis C; Ebert PA
Ann Thorac Surg; 1982 Jun; 33(6):549-53. PubMed ID: 6178379
[TBL] [Abstract][Full Text] [Related]
30. Antithrombotic Strategies After Bioprosthetic Aortic Valve Replacement: A Systematic Review.
Papak JN; Chiovaro JC; Noelck N; Healy LD; Freeman M; Quin JA; Paynter R; Low A; Kondo K; McCarty OJT; Kansagara D
Ann Thorac Surg; 2019 May; 107(5):1571-1581. PubMed ID: 30458159
[TBL] [Abstract][Full Text] [Related]
31. Anticoagulation and Antiplatelet Strategies After On-X Mechanical Aortic Valve Replacement.
Puskas JD; Gerdisch M; Nichols D; Fermin L; Rhenman B; Kapoor D; Copeland J; Quinn R; Hughes GC; Azar H; McGrath M; Wait M; Kong B; Martin T; Douville EC; Meyer S; Ye J; Jamieson WRE; Landvater L; Hagberg R; Trotter T; Armitage J; Askew J; Accola K; Levy P; Duncan D; Yanagawa B; Ely J; Graeve A;
J Am Coll Cardiol; 2018 Jun; 71(24):2717-2726. PubMed ID: 29903344
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of warfarin versus antiplatelet therapy in patients with a St. Jude Medical valve in the aortic position.
Hartz RS; LoCicero J; Kucich V; DeBoer A; O'Mara S; Meyers SN; Michaelis LL
J Thorac Cardiovasc Surg; 1986 Oct; 92(4):684-90. PubMed ID: 3762199
[TBL] [Abstract][Full Text] [Related]
33. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
[TBL] [Abstract][Full Text] [Related]
34. Aspirin or Coumadin as the drug of choice for valve replacement with porcine bioprosthesis.
Nuñez L; Aguado MG; Celemín D; Iglesias A; Larrea JL
Ann Thorac Surg; 1982 Apr; 33(4):354-8. PubMed ID: 7073379
[TBL] [Abstract][Full Text] [Related]
35. Warfarin or aspirin in embolism prevention in patients with mitral valvulopathy and atrial fibrillation.
Lavitola Pde L; Sampaio RO; Oliveira WA; Bôer BN; Tarasoutchi F; Spina GS; Grinberg M
Arq Bras Cardiol; 2010 Dec; 95(6):749-55. PubMed ID: 20976374
[TBL] [Abstract][Full Text] [Related]
36. Aniticoagulation in patients following prosthetic heart valve replacement.
Akhtar RP; Abid AR; Zafar H; Khan JS
Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of the antithrombotic strategy in low thrombotic risk patients who underwent aortic valve replacement with a bioprosthesis].
Aceves-Velázquez E; Vieyra-Herrera G; Rodríguez-Chávez L; Herrera-Alarcón V
Arch Cardiol Mex; 2018 Dec; 88(5):339-346. PubMed ID: 28720315
[TBL] [Abstract][Full Text] [Related]
38. Prevention of thromboembolic events after bioprosthetic aortic valve replacement: what is the optimal antithrombotic strategy?
Whitlock RP; Eikelboom JW
J Am Coll Cardiol; 2012 Sep; 60(11):978-80. PubMed ID: 22921974
[No Abstract] [Full Text] [Related]
39. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
Mok CK; Boey J; Wang R; Chan TK; Cheung KL; Lee PK; Chow J; Ng RP; Tse TF
Circulation; 1985 Nov; 72(5):1059-63. PubMed ID: 3899404
[TBL] [Abstract][Full Text] [Related]
40. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
